Brief: Vaxxel Acquires Transgene's DuckCelt-T17 Cell Line

Transgene SA

04/05/2020 07:11

May 4 (Reuters) - TRANSGENE SA  TRNG.PA :
    * VAXXEL ACQUIRES TRANSGENE'S DUCKCELT®-T17 CELL LINE TO
DEVELOP
INDUSTRIAL-SCALE VACCINES AGAINST RESPIRATORY VIRUSES
    * TRANSGENE BECOMES A SHAREHOLDER OF VAXXEL. DUCKCELT®-T17,
INITIALLY DEVELOPED AND PATENTED BY TRANSGENE, IS AN AVIAN CELL
LINE GROWN IN SUSPENSION

Source text for Eikon:  ID:nBw1ntVy5a 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))